CXM
Sprinklr, Inc.
CXM's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CXM overall, supported by stronger valuation and stronger modeled upside.
CXM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
CXM's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CXM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $6.65 | — |
| Cheap | 18x | $1.84 | -72% |
| Fair | 47x | $4.69 | -29% |
| Current | 67x | $6.65 | — |
| Expensive | 102x | $10.23 | +54% |
Historical ranges are pointers, not guarantees.
CXM's PE is in its expensive range at 67x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CXM in the historical PE scenario, which offers more potential upside but is not a forecast.
CXM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CXM's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CXM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.53 | +431% |
| Q3 2026 | $0.10 | -77% |
| Q2 2026 | $0.12 | -69% |
| Q1 2026 | $0.09 | -80% |
| Q4 2025 | $0.40 | +150% |
| Q3 2025 | $0.43 | +139% |
| Q2 2025 | $0.39 | +86% |
| Q1 2025 | $0.44 | +144% |
| Q4 2024 | $0.16 | +45% |
CXM's earnings per share have fallen from their peak: $0.10 over the past year, against $0.44 in early 2025.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CXM on earnings, with more consistent year-over-year improvement.
CXM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $213.7M | +0.8% |
| Q2 2026 | $219.5M | +6.8% |
| Q1 2026 | $220.6M | +8.9% |
| Q4 2025 | $219.1M | +9.2% |
| Q3 2025 | $212M | +7.5% |
| Q2 2025 | $205.5M | +4.9% |
| Q1 2025 | $202.5M | +4.3% |
| Q4 2024 | $200.7M | +7.7% |
CXM's revenue has grown year over year every quarter since early 2021: $214M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | -3 points |
| Q2 2026 | 4.8% | +5.7 points |
| Q1 2026 | 6.4% | +1.3 points |
| Q4 2025 | 5.3% | +1.3 points |
| Q3 2025 | 7.7% | +7.7 points |
| Q2 2025 | -0.8% | -3.8 points |
| Q1 2025 | 5.2% | -4.3 points |
| Q4 2024 | 3.9% | -3.1 points |
CXM's operating margin was 4.7% last quarter, down 3 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CXM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CXM on profitability, with a higher operating margin.
CXM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.8M | -48% |
| Q2 2026 | $70M | -16% |
| Q1 2026 | $20.1M | +341% |
| Q4 2025 | $19.8M | +141% |
| Q3 2025 | $34.4M | +74% |
| Q2 2025 | $83.5M | +113% |
| Q1 2025 | $4.6M | -70% |
| Q4 2024 | $8.2M | -57% |
CXM generated $128M in free cash flow over the past year, down 2.3% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CXM on cash flow, with more consistent year-over-year improvement.
CXM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -5.3M shares |
| 1 year | -9.6% | -25.4M shares |
| 3 years | -16% | -46M shares |
| 5 years | -5% | -12.6M shares |
| Available history | +2.8% | +6.4M shares |
CXM has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $796,000 |
| Q2 2026 | $125M |
| Q1 2026 | — |
| Q4 2025 | $11.4M |
| Q3 2025 | $140.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
CXM spent $137M buying back its own shares over the past year, down 2.6% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CXM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.6x | Net Cash |
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -3.6x | Net Cash |
| Q1 2025 | -3.4x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
CXM has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CXM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.8 | Neutral |
| Stochastic | 55.9 | Neutral |
CXM's weekly RSI is 56 (neutral) and its Stochastic is 56 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CXM PE vs Technology Sector
| Metric | CXM | Sector median | Relative |
|---|---|---|---|
| PE | 67x | 28x | 139% above |
| PE % | 77 | 43 | 34 pts above |
CXM is trading at 67x earnings, a 139% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CXM on valuation relative to its sector.
CXM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.05 | 9.9% above |
| 20 week MA | $6.16 | 8% above |
| 50 week MA | $6.10 | 9% above |
| 100 week MA | $7.15 | 7% below |
| 200 week MA | $9.36 | 29% below |
CXM has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CXM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.5 | $16.0 | -22% |
| 2022 | $16.0 | $7.84 | -51% |
| 2023 | $7.84 | $12.0 | +54% |
| 2024 | $12.0 | $8.53 | -29% |
| 2025 | $8.53 | $7.72 | -9.5% |
| 2026 YTD | $7.72 | $6.65 | -14% |
CXM has finished lower in four of the last five years. It's down 14% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CXM on returns for 2026, with the stronger performance.